scholarly article | Q13442814 |
P2093 | author name string | Kumar Pushpanshu | |
Rachna Kaushik | |||
Ramhari S Sathawane | |||
P2860 | cites work | HIV in the oral cavity: virus, viral inhibitory activity, and antiviral antibodies: a review | Q28262566 |
The role of the oral environment in HIV-1 transmission | Q28278090 | ||
Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus | Q28288820 | ||
Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro | Q28293679 | ||
Endogenous mucosal antiviral factors of the oral cavity | Q33547138 | ||
Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity | Q33780434 | ||
Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients | Q33997956 | ||
Oral transmission of HIV, reality or fiction? An update | Q34526020 | ||
The anti-HIV-1 activity associated with saliva | Q34738486 | ||
Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids | Q35075174 | ||
Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues. | Q35764264 | ||
Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk | Q36055396 | ||
Role of human beta-defensins in HIV infection | Q36467656 | ||
Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons | Q37116400 | ||
Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age. | Q43699128 | ||
Salivary secretory leukocyte protease inhibitor increases in HIV infection | Q44548017 | ||
Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission | Q45738773 | ||
Components of saliva inactivate human immunodeficiency virus | Q45840053 | ||
Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus | Q72578669 | ||
P433 | issue | 1 | |
P304 | page(s) | 26-30 | |
P577 | publication date | 2014-01-01 | |
P1433 | published in | Indian Journal of Palliative Care | Q15710015 |
P1476 | title | Estimation and comparison of salivary secretory leukocyte protease inhibitor in human immunodeficiency virus patients and healthy individuals | |
P478 | volume | 20 |
Q40686286 | Secretory Leukocyte Protease Inhibitor Expression and High-Risk HPV Infection in Anal Lesions of HIV-Positive Patients. | cites work | P2860 |
Search more.